Key result
Total revascularization is linked to ~67% less recurrent chest pain and fewer MIs vs culprit-only PCI.
Why the study?
The study was designed to compare clinical outcomes between culprit-only revascularization and total revascularization in patients with STEMI undergoing primary PCI.
Does total revascularization reduce major adverse cardiovascular events in STEMI patients with multivessel disease undergoing primary PCI compared to culprit-only revascularization?
Observational (n=50)
Yes
Does total revascularization reduce major adverse cardiovascular events in STEMI patients with multivessel disease undergoing primary PCI compared to culprit-only revascularization?
In STEMI patients with multivessel disease, total revascularization during primary PCI is safe and significantly reduces non-fatal MI and recurrent chest pain at 6 months compared to culprit-only revascularization.
Answers are grounded in this paper and cite their sources.
Supports complete revascularization in multivessel STEMI; leaves open confirmation of MACE reduction in randomized trials.
Objectives: To compare between only Culprit revascularization versus total revascularization in patients with ST-elevation myocardial infarction undergoing primary PCI with 6 months follow up of occurrence of major adverse cardiovascular events (MACCE). Methods: 50 patients were enrolled in this study during the period from 1/11/2018 to 1/11/2019 at Menoufiya University and national heart institute. All patients present with acute ST-elevation myocardial infarction within 24 hours of onset of symptoms, and have multi vessel coronary artery disease on angiography suitable for PCI. Patients were subjected to detailed medical history, physical examination, and electrocardiography. Results: 50 patients with acute ST-elevation myocardial infarction (28 females and 22 males) underwent primary percutaneous coronary intervention. 25 patients had total revascularization to all coronary arteries, the other 25 patients had only culprit revascularization. We found that there was a significant reduction in the incidence of recurrent chest pain and non-fatal Myocardial infarction in the total revascularization group. Conclusion: Our study showed that Multivessel revascularization resulted in an improved clinical course and a significant reduction of MACCE regarding non-fatal MI and a significant reduction of recurrent chest pain.
No takes yet. Share an insight, caveat, or question.
Nawar et al. (2019) conducted an observational in ST-elevation myocardial infarction with multivessel coronary artery disease (n=50). Total revascularization vs. Culprit-only revascularization was evaluated on Non-fatal myocardial infarction (p=0.018). Total revascularization reduced the incidence of non-fatal myocardial infarction and recurrent chest pain at 6 months compared to culprit-only revascularization.
Synapse has enriched 10 related papers. Consider them for comparative context: